טוען...
Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
BACKGROUND: In non-dialysis chronic kidney disease (CKD) patients with dyslipidemia, statin therapy is recommended to prevent cardiovascular complications. Dyslipidemia has been also shown to be an independent risk factor for the progression of CKD. However, it is still unclear whether statin therap...
שמור ב:
| הוצא לאור ב: | Lipids Health Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4673714/ https://ncbi.nlm.nih.gov/pubmed/26645467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-015-0164-5 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|